alpha-BLOCKERS FOR THE TREATMENT OF CHRONIC PROSTATITIS IN COMBINATION WITH ANTIBIOTICS

Barbalias, George A.; Nikiforidis, George; Liatsikos, E.

doi:10.1097/00005392-199803000-00073

Cited by 21 publications

(26 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…When the administration of antibiotics alone is not effective, some patients may benefit from combination therapy including -blockers [12] or repetitive prostatic massage [13].…”

Section: Category Ii: Chronic Bacterial Prostatitismentioning

confidence: 99%

New therapies in chronic prostatitis

Dhar

Shoskes

2007

Curr Urol Rep

View full text Add to dashboard Cite

The optimal management of category III prostatitis (chronic pelvic pain syndrome) is not known. Conventional therapy usually consists of prolonged courses of antibiotics; however, clinical trials have never shown their efficacy. Newer therapies with some evidence for efficacy include alpha-blockers, anti-inflammatory phytotherapy (quercetin, bee pollen), physiotherapy, neuroleptics, and others with unique actions such as antinanobacterial treatment. A stepwise approach involving multiple treatment modalities is often successful for patients with this common and frustrating condition.

show abstract

“…When the administration of antibiotics alone is not effective, some patients may benefit from combination therapy including -blockers [12] or repetitive prostatic massage [13].…”

Section: Category Ii: Chronic Bacterial Prostatitismentioning

confidence: 99%

New therapies in chronic prostatitis

Dhar

Shoskes

2007

Curr Urol Rep

View full text Add to dashboard Cite

show abstract

“…Le rationnel d'utiliser des alphabloqueurs est que ces derniers permettent de diminuer le reflux d'urine dans les conduits intraprostatiques améliorant le débit urinaire en relaxant le col vésical et la prostate [5,31]. Plusieurs études ont démontré une amélioration significative des symptômes après six semaines de traitement soit avec la térazosine [25,42], la doxazosine [20], la tamsulosine [35] ou l'alfusozin [6]. L'efficacité des alphabloqueurs est équivalente peu importe l'agent utilisé.…”

Section: Antibiotiquesunclassified

Painful urological syndromes overview of the diagnosis and treatment of painful bladder syndrome/interstitial cystitis and chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CPPS)

Sabbagh

2007

Douleur analg.

View full text Add to dashboard Cite

Douleurs urologiquesMise à jour sur le diagnostic et le traitement du syndrome de la vessie douloureuse/cystite interstitielle et de la prostatite chronique non bactérienne/syndrome de la douleur pelvienne chronique (SDPC)Painful urological syndromes Overview of the diagnosis and treatment of painful bladder syndrome/interstitial cystitis and chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CPPS) LM. Tu, R. SabbaghRésumé : Le syndrome de la vessie douloureuse/cystite interstitielle (SVD/CI) et de la prostatite chronique non bactérienne/syndrome de douleur pelvienne chronique (PCNB/SDPC) sont des entités urologiques sous-estimées et sous-diagnostiquées par le manque de connaissances des médecins. L'étiologie est inconnue et multifactorielle, ce qui entraîne une combinaison de multiples agents thérapeutiques. Cet article fera une mise à jour de ces deux pathologies urologiques douloureuses.Mots clés : Cystite interstitielle -Syndrome de la vessie douloureuse -Syndrome de la douleur pelvienne chronique -Prostatite chronique non bactérienne Abstract: Painful bladder syndrome/interstitial cystitis and category III prostatitis/chronic pelvic pain syndrome are underestimated and underdiagnosed due to a lack of knowledge on the part of physicians. The ethiology is unknown and possibly multifactorial, which explains the association of different agents and the application of a multimodality approach to control the symptoms. This article will give an overview of these two entities. Syndrome de la vessie douloureuse/cystite interstitielle Gé né ralitéLa cystite interstitielle a été rapportée au début du XIX e siècle comme étant un état inflammatoire sous forme

show abstract

“…Bei sich überschneidender Symptomatik findet man bei der chronischen abakteriellen Prostatitis eine Ansprechrate von 48-76% [6,15,19,28,35].…”

Section: α-Blockerunclassified